Tamas Banyasz (Tamás Bányász)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Cardiac Resynchronization Therapy

Hypertrophic Cardiomyopathy

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Naveed, Aiman Saleh A Mohammed, Leila Topal, Zsigmond Máté Kovács, Csaba Dienes, József Ovári, Norbert Szentandrássy, János Magyar, Tamas Banyasz, János Prorok, Norbert Jost, László Virág, Istvan Baczko, András Varró, Péter P Nánási, Balázs Horváth
Selective Inhibition of Cardiac Late Na + Current Is Based on Fast Offset Kinetics of the Inhibitor. Biomedicines 11 (9) (2023)
Balázs Horváth, Zsigmond M Kovács, Csaba Dienes, József Óvári, Norbert Szentandrássy, János Magyar, Tamas Banyasz, András Varró, Péter P Nánási
Conductance Changes of Na + Channels during the Late Na + Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Balázs Horváth, Zsigmond M Kovács, Csaba Dienes, József Óvári, Norbert Szentandrássy, János Magyar, Tamas Banyasz, András Varró, Péter P Nánási
Conductance Changes of Na + Channels during the Late Na + Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Zsigmond Máté Kovács, József Óvári, Csaba Dienes, János Magyar, Tamas Banyasz, Péter P Nánási, Balázs Horváth, Ádám Fehér, Zoltan Varga, Norbert Szentandrássy
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of I Kr . Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Zsigmond Máté Kovács, József Óvári, Csaba Dienes, János Magyar, Tamas Banyasz, Péter P Nánási, Balázs Horváth, Ádám Fehér, Zoltan Varga, Norbert Szentandrássy
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of I Kr . Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Balázs Horváth, Zsigmond M Kovács, Csaba Dienes, József Óvári, Norbert Szentandrássy, János Magyar, Tamas Banyasz, András Varró, Péter P Nánási
Conductance Changes of Na + Channels during the Late Na + Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Zsigmond Máté Kovács, József Óvári, Csaba Dienes, János Magyar, Tamas Banyasz, Péter P Nánási, Balázs Horváth, Ádám Fehér, Zoltan Varga, Norbert Szentandrássy
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of I Kr . Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Zsigmond Máté Kovács, József Óvári, Csaba Dienes, János Magyar, Tamas Banyasz, Péter P Nánási, Balázs Horváth, Ádám Fehér, Zoltan Varga, Norbert Szentandrássy
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of I Kr . Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Balázs Horváth, Zsigmond M Kovács, Csaba Dienes, József Óvári, Norbert Szentandrássy, János Magyar, Tamas Banyasz, András Varró, Péter P Nánási
Conductance Changes of Na + Channels during the Late Na + Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Balázs Horváth, Norbert Szentandrássy, János Almássy, Csaba Dienes, Zsigmond Máté Kovács, Péter P Nánási, Tamas Banyasz
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going? Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Norbert Szentandrássy, Zsuzsanna É Magyar, Judit Hevesi, Tamas Banyasz, Péter P Nánási, János Almássy
Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases. International journal of molecular sciences 23 (8) (2022)